Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 14 Show results per page	View Search Criteria \| Help With Results

Last Modified: 7/10/2007 First Published: 9/15/2006


1.		Phase IV Randomized Pilot Study of Oxycodone Hydrochloride Versus Standard Three-Step Analgesic Therapy in Patients With Cancer-Related Pain

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Supportive care				Closed				18 and over				Other, Pharmaceutical / Industry				CRUK-ON/2003/1772 EU-20640, EUDRACT-2004-004235-66, NAPP-CRUK-ON/2003/1772, NCT00378937

Last Modified: 7/11/2007 First Published: 2/1/1999


2.		Phase III Randomized Study of Two Different Sustained Release Formulations of Morphine Followed By Dextromethorphan or Placebo Plus Morphine for Patients with Chronic Cancer Pain

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Completed				16 and over				Other				CAN-NCIC-SC17 NCT00003687, SC17


3.		Double Bedtime Dosing During Immediate-Release Morphine Administration to Cancer Patients

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Completed				Over 18				Other				OPI 02/001 NCT00201539

Last Modified: 10/1/1997 First Published: 10/1/1997


4.		Phase II Study of Preemptive Administration of Epidural Morphine Sulfate to Provide Better Postoperative Pain Control in Patients Undergoing Thoracotomies for Cancer (Summary Last Modified 10/97)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Supportive care				Closed				18 and over				Other				RPCI-DS-93-48 NCI-V97-1252

Last Modified: 2/1/2002 First Published: 7/1/2001


5.		Phase II Randomized Study of Aerosolized Versus Oral Morphine Sulfate in Cancer Patients With Opioid-Sensitive Breakthrough Pain (Summary Last Modified 02/2002)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Supportive care				Completed				18 and over				Pharmaceutical / Industry				DFCI-MOR-00-01 ARADIGM-MOR-00-01, BWH-2000-P-001516, NCT00020618

Last Modified: 6/1/1990


6.		Phase II Study of the Management of Severe Pain Due to Pancreatic Cancer (Summary Last Modified 06/90)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Supportive care				Closed				any age								RPMI-DS-8815 NCI-V88-0552


7.		A Efficacy and Safety Trial of Controlled Release (CR) Morphine in Cancer Patients

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Supportive care				Completed				18 and over				Pharmaceutical / Industry				MP-EG-002 EudraCT number: 2006-006579-19, NCT00446069


8.		Bioavailability and Effectiveness of Transdermally Administered Morphine

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Supportive care				Completed				18 to 65				Other				10181 NCT00125684

Last Modified: 6/1/1995


9.		Randomized Study of Nebulized vs Subcutaneous Morphine for Dyspnea in Terminal Cancer Patients (Summary Last Modified 06/95)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Supportive care				Closed				over 20								YALE-HIC-7849 NCI-V94-0591

Last Modified: 5/14/2007


10.		Randomized Study of the Peripheral Effects of Opioid Analgesia in Patients with Breast Cancer Undergoing Axillary Node Dissection (Summary Last Modified 07/2000)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Natural history/Epidemiology				Closed				no age specified				Other				RPCI-DS-92-13 NCI-V97-1251, NCT00003000

Select All on One Page


					1 2 Next >

| | | | | | | |

A Service of the National Cancer Institute